Levetiracetam treats seizure disorders.
Medication is taken orally daily.
Take doses at the same time every day.
Take doses without regard to food.
Levetiracetam is a generic prescription anticonvulsant used alone or along with other drugs for certain types of seizures. The drug helps prevent seizures by slowing down nerve activity. Doses are taken orally every day—twice daily for immediate-release formulations, and once daily for the extended-release version. If a patient cannot swallow pills, an oral disintegrating tablet is available, or a healthcare professional can administer the medication via intravenous injections.
Levetiracetam comes in several dosage forms as well as several brand names, including Keppra, Roweepra, Elepsia XR, and Spritam:
Tablets: 250 mg, 500 mg, 750 mg, 1,000 mg
Disintegrating oral tablets: 250 mg, 500 mg, 750 mg, 1000 mg
Extended-release tablets: 500 mg, 750 mg, 1,000 mg, 1,500 mg
Tablets for suspension: 250 mg, 500 mg, 750 mg, 1,000 mg
Oral solution (liquid): 100 mg/mL
Injection: 100 mg/mL
Levetiracetam is FDA approved for the adjunctive therapy of myoclonic seizures, partial seizures, and tonic-clonic seizures. Healthcare professionals may also use it off-label to treat prolonged seizures (status epilepticus) or to prevent seizures after a traumatic brain injury or subarachnoid bleed in the brain.
Levetiracetam is safe to take. The only contraindication is a history of an allergic or drug reaction to levetiracetam.
Check our best Levetiracetam prices
Levetiracetam dosage chart |
|||
|---|---|---|---|
| Indication | Starting dosage | Standard dosage | Maximum dosage |
| Partial onset seizures | 500 mg levetiracetam IR taken twice daily OR 1,000 mg levetiracetam ER taken once daily | 1,500 mg levetiracetam IR taken twice daily OR 3,000 mg levetiracetam ER taken once daily | 3,000 mg daily |
| Juvenile myoclonic seizures | 500 mg levetiracetam IR taken twice daily | 1,500 mg levetiracetam IR taken twice daily | 3,000 mg daily |
| Tonic-clonic seizures | 500 mg levetiracetam IR taken twice daily | 1,500 mg levetiracetam IR taken twice daily | 3,000 mg daily |
Levetiracetam is an anti-seizure drug. As maintenance therapy, it helps reduce the frequency and severity of seizures. Doctors prescribe levetiracetam alone as monotherapy, but seizures are often difficult to stop completely, and polytherapy (taking more than one antiseizure medication) is often needed.
Levetiracetam treats only some types of seizure disorders in adult patients: partial onset seizures, juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures.
People usually take immediate-release levetiracetam twice daily, but patients with partial seizures can be prescribed extended-release tablets, which require only one dose daily. People who can’t swallow a tablet can opt for liquid or oral-disintegrating versions. If a person can’t take medication orally, doctors will use intravenous injections.
Doses start low at 1,000 mg daily (two 500 mg tablets twice daily). Doses increase by 1,000 increments every two weeks to reach the target dose of 3,000 mg per day (1,500 mg twice daily).
Standard adult dosage for seizure disorders: 3,000 mg daily
Maximum adult dosage for seizure disorders: 3,000 mg daily
The FDA approved levetiracetam for use in pediatric patients, but the age range depends on the type of seizure disorder being treated:
Partial seizures: levetiracetam can be used in children as young as 1 month old—dosages are based on weight for children younger than 4 years of age
Juvenile myoclonic seizures: levetiracetam is only approved in children 12 years of age and older
Tonic-clonic seizures: levetiracetam treats children 6 years of age and older
Extended-release levetiracetam is only approved to treat partial seizures in adults and children as young as 12. Dosages are the same for adults and children.
There is no children’s formulation of levetiracetam, but doctors will prescribe levetiracetam oral solution for children 4 years of age or younger or children who weigh less than 20 kg (44 lbs.). They can also use intravenous injections. Unlike the use of tablets, oral solution or injection doses will be based on the child’s exact body weight.
Standard levetiracetam dosage for children 1–6 months of age: 7–21 mg/kg levetiracetam oral solution taken twice daily
Standard levetiracetam dosage for children 6 months to 4 years of age: 10–25 mg/kg levetiracetam oral solution or injection administered twice daily
Standard levetiracetam dosage for children 4–16 years of age and weighing 20–40 kg: 10–30 mg/kg levetiracetam oral solution or injection or 250–750 mg immediate-release tablets administered twice daily
Standard levetiracetam dosage for children 4–16 years of age and weighing 40 kg or more: 10–30 mg/kg levetiracetam oral solution or 250–750 mg immediate-release tablets taken twice daily
Standard extended-release levetiracetam dosage for children 12 years of age and older and weighing 50 kg or more: 250–750 mg extended-release tablets taken once daily
Levetiracetam dosage by age and weight |
|||
|---|---|---|---|
| Age | Weight | Recommended dosage (liquid) | Recommended dosage (tablets) |
| 1–6 months | 7–21 mg/kg taken twice daily | ||
| 6 months–4 years | 10–25 mg/kg taken twice daily | ||
| 4–16 years | 20–40 kg | 10–30 mg/kg taken twice daily | 250–750 mg IR tablets taken twice daily |
| ≥40 kg | 500–1,500 mg IR tablets taken twice daily | ||
| ≥12 years of age | ≥50 kg | 1,000–3,000 mg extended-release tablets taken once daily |
Levetiracetam dosages require no modifications for people with liver disease (hepatic impairment). However, doses must be individualized for people with kidney disease as follows:
Patients with renal impairment (kidney disease):
Mild renal impairment (creatinine clearance 50–80 mL/min): 500 to 1,000 mg taken twice daily
Moderate renal impairment (creatinine clearance 30–50 mL/min): 250 to 750 mg taken twice daily
Severe renal impairment (<30 mL/min): 250 to 500 mg taken twice daily
End-stage renal disease and dialysis: 500 to 1,000 mg taken once daily
Veterinarians use levetiracetam for seizure disorders in dogs and cats. It’s not their first choice, but they will use it for refractory epilepsy not controlled by other drugs.
Veterinarians consider levetiracetam a safe drug. The most common side effects in dogs are vomiting and salivation.
The standard levetiracetam dosage in dogs and cats is 20 mg per kilogram of body weight given every eight hours.
Levetiracetam comes in a variety of dosage formats, including extended-release formulations. Check the Medication Guide from the pharmacist before you start taking doses to make sure you are taking the medicine correctly. Here are a few guidelines:
Follow all the prescriber’s instructions.
Do not change the dose or take doses more frequently than prescribed.
Please read the Drug Information sheet and the Medication Guide from the pharmacist that comes with this medicine.
Take doses at the same time each day.
Take doses with or without food.
Do not stop taking levetiracetam without consulting with the prescriber.
Levetiracetam immediate-release tablets
Take doses twice daily unless instructed otherwise.
Swallow the tablet whole. Do not crush, break, or chew it.
Store the tablets at room temperature. Protect from heat and light.
Extended-release levetiracetam tablets
Take doses once per day unless instructed otherwise.
Swallow the tablet whole. Do not crush, break, or chew it.
Store the tablets at room temperature. Protect from heat and light.
High-dose extended-release levetiracetam tablets (Elepsia XR)
Take doses once daily unless instructed otherwise.
Swallow the tablet whole. Do not crush, break, divide, or chew it.
Each tablet has a blue layer and a white layer. If either the blue or white layer is missing, do not take the tablet.
Some inert parts of the tablet may be visible in stools. This is normal.
Store the tablets at room temperature protected from light.
Tablets for suspension (Spritam)
Take Spritam tablets two times daily unless instructed otherwise.
Tablets can be dissolved in the mouth or in a small amount of liquid.
Dry your hands before removing a Spritam tablet from the blister pack.
Peel back the foil.
Empty the tablet from the blister pack into a dry hand. Do not push the tablet through the foil.
Place the tablet on your tongue.
Take a sip of liquid.
Allow the tablet to fully dissolve in the liquid. This usually takes about 11 seconds but could take as long as 27 seconds.
When the tablet has fully dissolved, swallow the solution.
The tablet can also be placed in one tablespoon of liquid and dissolved by swirling the liquid. Swallow the suspension immediately. If any medicine is left over, add a bit more liquid and drink it.
Store Spritam tablets in their blister pack at room temperature.
Levetiracetam oral solution
Take doses twice daily unless instructed otherwise.
Ask the pharmacist for a calibrated oral syringe, dropper, or medicine cup to measure doses. Do not use kitchen measuring devices or tableware.
Store levetiracetam oral solution at room temperature, away from heat and light.
The two formulations have the same daily dose of levetiracetam, though extended-release levetiracetam is taken only once daily.
Take a missed dose as soon as you remember it. If it’s almost time for the next dose, skip the missed dose and take the next dose as scheduled. Do not double up doses to compensate for a missed dose.
Do not stop taking levetiracetam without first making a plan with your healthcare provider. Sudden discontinuation of levetiracetam could cause frequent and potentially severe seizures. The doctor may need to taper the dose gradually to prevent seizures.
The maximum dosage of levetiracetam is 3,000 mg daily.
Doctors usually advise people with seizures to avoid alcohol. Drinking can trigger seizures, and seizure medications like levetiracetam can lower the body’s tolerance for alcohol. Combining alcohol with levetiracetam will also worsen side effects like extreme drowsiness, poor coordination, and dizziness. Consider also that most patients will also be taking other sedating anticonvulsants like phenobarbital, diazepam, or lorazepam, so all these sedative drug interactions could add up to significant impairment when alcohol is added to the mix.
Healthcare providers aren’t sure if levetiracetam is safe for an unborn baby, but it is associated with birth defects in animals. Pregnant women are encouraged to register with the North American Antiepileptic Drug (NAAED) pregnancy registry when taking levetiracetam.
One major concern is that levetiracetam’s pharmacokinetics change in the later stages of pregnancy. For reasons not understood, pregnant women eliminate the drug more quickly, so the drug may be less effective at preventing seizures. Clinicians are cautioned to regularly monitor pregnant women to make sure the drug is working.
Levetiracetam is present in breast milk and detectable at low levels in a nursing infant. However, sometimes levetiracetam levels could be high in some women’s breast milk and make the baby sleepy. Women can take the drug while breastfeeding but should monitor the baby for unusual drowsiness. Immediately report any problems to the prescriber.
In clinical trials, the most common side effects of levetiracetam were drowsiness, weakness, dizziness, infection, and aggression. Serious adverse effects include suicidal thoughts, abnormal behaviors, hallucinations, high blood pressure, kidney problems, liver problems, and severe allergic or drug reactions such as angioedema, anaphylaxis, and skin reactions.
Alcohol as a seizure trigger, Epilepsy Foundation
Keppra drug summary, Prescriber’s Digital Reference (PDR)
Elepsia XR 1000 mg/1500 mg levetiracetam extended-release tablet prescribing information, DailyMed (NIH National Library of Medicine)
Keppra levetiracetam tablet/levetiracetam solution prescribing information, DailyMed (NIH National Library of Medicine)
Keppra XR levetiracetam extended-release tablet prescribing information, DailyMed (NIH National Library of Medicine)
Levetiracetam, StatPearls
Levetiracetam injection prescribing information, DailyMed (NIH National Library of Medicine)
Plumb’s Veterinary Drug Handbook, 7th ed.
Spritam levetiracetam tablet for suspension prescribing information, DailyMed (NIH National Library of Medicine)
Leslie Greenberg, MD, is a board-certified practicing family physician with more than 25 years of doctoring experience. She was a psychology major at Northwestern University near Chicago, then graduated with an MD from the University of Nevada School of Medicine. She completed her family medicine residency at St. Joseph Hospital in Wichita, Kansas. She has trained more than 350 family medicine resident-physicians, been in private practice, and delivered babies for 22 years.
...Los ahorros en recetas varían según la receta médica y la farmacia, y pueden alcanzar hasta un 80% de descuento sobre el precio en efectivo. Este es un plan de descuento de recetas médicas. NO es un seguro ni un plan de medicamentos de Medicare. El rango de descuentos para las recetas médicas que se brindan bajo este plan, dependerá de la receta y la farmacia donde se adquiera la receta y puede otorgarse hasta un 80% de descuento sobre el precio en efectivo. Usted es el único responsable de pagar sus recetas en la farmacia autorizada al momento que reciba el servicio, sin embargo, tendrá el derecho a un descuento por parte de la farmacia de acuerdo con el Programa de Tarifas de Descuento que negoció previamente. Towers Administrators LLC (que opera como “SingleCare Administrators”) es la organización autorizada del plan de descuento de recetas médicas ubicada en 4510 Cox Road, Suite 11, Glen Allen, VA 23060. SingleCare Services LLC (“SingleCare”) es la comercializadora del plan de descuento de prescripciones médicas que incluye su sitio web www.singlecare.com. Como información adicional se incluye una lista actualizada de farmacias participantes, así como también asistencia para cualquier problema relacionado con este plan de descuento de prescripciones médicas, comunícate de forma gratuita con el Servicio de Atención al Cliente al 844-234-3057, las 24 horas, los 7 días de la semana (excepto los días festivos). Al utilizar la aplicación o la tarjeta de descuento para recetas médicas de SingleCare acepta todos los Términos y Condiciones, para más información visita: https://www.singlecare.com/es/terminos-y-condiciones. Los nombres, logotipos, marcas y otras marcas comerciales de las farmacias son propiedad exclusiva de sus respectivos dueños.
Los artículos del blog no constituyen asesoramiento médico. Su propósito es brindar información general y no sustituyen el asesoramiento, diagnóstico ni tratamiento médico profesional. Si tiene alguna pregunta sobre una afección médica, consulte siempre a su médico u otro profesional de la salud cualificado. Si cree tener una emergencia médica, llame inmediatamente a su médico o al 911.
© 2025 SingleCare Administrators. Todos los derechos reservados
© 2025 SingleCare Administrators. Todos los derechos reservados